Indian generic injectables maker Gland Pharma reported a 7% rise in third-quarter profit on Monday, as lower expenses helped mitigate the impact from production issues at its French unit Cenexi. The ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Divi's Laboratories, Religare Enterprises Ltd, Tata Chemicals, Asian Paints, One Mobikwik , Tata Power Co. Ltd, Titan, ...

Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture company set up by Zydus Lifesciences Limited and Takeda ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements.

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

In the first randomized trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not ...

Pankaj R Patel, the Chairman of Zydus Lifesciences Limited, has been conferred with one of India's highest civilian honours by the central government. "I am honoured to receive this recognition and ...

The Ahmedabad -based Patel, whose Zydus Group runs a chain of multi-specialty hospitals, further said, “We are taking a leap ...

Innovation from India will bring critical access to affordable healthcare and empower people to lead healthier and more fulfilled lives, said Zydus Lifesciences Chairman Pankaj R Patel who has been ...

Zydus Lifesciences Chairman Pankaj R Patel awarded Padma Bhushan for contributions to healthcare innovation. Patel emphasizes ...

Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.